Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
FOXO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-65.67
vs -21.22
Q2.23
N/A
-79.60
vs -38.45
Q3.23
N/A
-0.75
vs -1333.33
Q4.23
N/A
-0.57
vs -17.53
Q1.24
N/A
-4.78
vs -65.67
Q2.24
N/A
-4.78
vs -79.60
Q3.24
N/A
-0.15
vs -0.75
Q4.24
N/A
-0.31
vs -0.57
Q1.25
N/A
-0.74
vs -4.78
Q2.25
N/A
-4.78
vs -4.78
Sales Growth
YoY
Current
Estimates
Q1.23
-67%
13K vs 40K
Q2.23
-69%
12K vs 39K
Q3.23
-29%
10K vs 14K
Q4.23
-74%
110K vs 418K
Q1.24
-46%
7K vs 13K
Q2.24
+133%
28K vs 12K
Q3.24
+11860%
1.2M vs 10K
Q4.24
+2464%
2.8M vs 110K
Q1.25
+45185%
3.2M vs 7K
Q2.25
+18537%
5.2M vs 28K
Return on Equity
QoQ
Q1.23
+25463%
254.63
vs -7.17
Q2.23
+161%
1.61
vs 254.63
Q3.23
+33%
0.33
vs 1.61
Q4.23
+27%
0.27
vs 0.33
Q1.24
+10%
0.1
vs 0.27
Q2.24
+13%
0.13
vs 0.1
Q3.24
+11%
0.11
vs 0.13
Q4.24
0%
-0.00
vs 0.11
Q1.25
-6%
-0.06
vs -0.00
Q2.25
-4%
-0.04
vs -0.06
Institutionnal Ownership
QoQ
Q1.23
NA
NA
vs NA
NA
Q2.23
NA
NA
vs NA
NA
Q3.23
NA
NA
vs NA
NA
Q4.23
9
9
vs NA
NA
Q1.24
11
11
vs 9
22%
Q2.24
10
10
vs 11
-9%
Q3.24
12
12
vs 10
20%
Q4.24
17
17
vs 12
42%
Q1.25
11
11
vs 17
-35%
Q2.25
1
1
vs 11
-91%
globenewswire.com
7 hours ago
businesswire.com
16 hours ago
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
AMEX
Unprofitable
Unprofitable
-0.00 ( -21.88%)
After-hours 0.00$
0.00 (-3.00%)
Relative Strenght
1
Volume Buzz
-50%
Earning Acce
No
Dist 52w H.
100%Relative Strength
FOXO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|